Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
نویسندگان
چکیده
We report the effects of enzyme replacement therapy in a patient with Gaucher's disease associated with a monoclonal gammopathy. Alglucerase induces a linear decline in immunoglobulin and beta 2-microglobulin levels. This observation suggests that this treatment decreases the chronic antigenic stimulation commonly found in Gaucher's disease.
منابع مشابه
Enzyme replacement therapy in the management of longstanding skeletal and soft tissue salmonella infection in a patient with Gaucher's disease.
A splenectomised patient with Gaucher's disease who developed multiple foci of osteomyelitis and soft tissue abcesses, after a severe episode of group C salmonella sepsis, is described. Aggressive antibiotic treatment and surgical drainage had little effect and the patient's condition continued to deteriorate. With initiation of enzyme replacement therapy (ERT) in addition to specific antibioti...
متن کاملFibromyalgia and Gaucher's disease.
BACKGROUND Patients with symptomatic Gaucher's disease sometimes have non-specific symptoms (such as general malaise with widespread musculoskeletal pains) that respond poorly to enzyme replacement treatment. These may indicate fibromyalgia syndrome; if so, other therapeutic options might be more appropriate. AIM To identify patients with Gaucher's disease for whom fibromyalgia-specific thera...
متن کاملEnzyme replacement therapy for Gaucher's disease: the early Canadian experience.
BACKGROUND The management of severe Gaucher's disease was dramatically improved by the development of enzyme replacement therapy. However, this treatment is very costly (currently about $21,000 per infusion for adults at the starting dose recommended by the manufacturer). The goal of this study was to determine how enzyme replacement therapy was being prescribed and financially supported in var...
متن کاملTotal hip replacement in Gaucher's disease: effects of enzyme replacement therapy.
Total hip replacement in patients with Gaucher's disease with symptomatic osteonecrosis of the femoral head is controversial because of the high early failure rates. We describe four patients who had an uncemented total hip replacement following enzyme replacement therapy for a median of two years and one month (1 to 9.8 years) prior to surgery, and who remained on treatment. At operation, the ...
متن کاملHematologic response in type I Gaucher's disease after enzyme replacement therapy.
Sir, Gaucher's disease is a sphingolipidosis characterized by recessive autosomal transmission. It is often accompanied by normochromic normocytic anemia which almost never requires transfusion therapy. Continued therapy using enzyme replacement is currently a treatment choice for this rare and as yet little studied disease. The neurologic and liver damage linked to metabolic abnormalities are ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Haematologica
دوره 83 5 شماره
صفحات -
تاریخ انتشار 1998